The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients
暂无分享,去创建一个
P. Neven | H. Wildiers | G. Floris | F. Puglisi | M. Paesmans | L. Ameye | E. de Azambuja | M. Lambertini | F. Poggio | L. Del Mastro | A. C. Pinto | M. Bonotto | H. Azim Jr. | K. Van Asten | L. Jongen
[1] L. V. van't Veer,et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.
[2] N. Davidson,et al. Challenges in Treating Premenopausal Women with Endocrine-Sensitive Breast Cancer. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[3] Alberto Revelli,et al. Cancer and fertility preservation: international recommendations from an expert meeting , 2016, BMC Medicine.
[4] R. Gelber,et al. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] M. Teare,et al. Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience , 2015, BMJ Open.
[6] N. Tinari,et al. Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study , 2014, Breast Cancer Research and Treatment.
[7] A. Partridge,et al. Biology of breast cancer in young women , 2014, Breast Cancer Research.
[8] H. Putter,et al. Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study. , 2014, The Lancet. Oncology.
[9] E. Smets,et al. Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Coffey,et al. Correlation between Nottingham Prognostic Index and Adjuvant! Online prognostic tools in patients with early-stage breast cancer in Mid-Western Ireland. , 2013, Clinical breast cancer.
[11] L. Vatten,et al. Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients , 2013, Breast Cancer Research and Treatment.
[12] P. Neven,et al. Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] H. Verkooijen,et al. Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients. , 2012, European journal of cancer.
[14] M. J. van de Vijver,et al. External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement , 2011, PloS one.
[15] M. Piccart,et al. Long-term toxic effects of adjuvant chemotherapy in breast cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] Chin-Tsang Chiang,et al. Non‐parametric estimation for time-dependent AUC , 2010 .
[17] S. Mook,et al. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. , 2009, The Lancet. Oncology.
[18] A. Harris,et al. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom , 2009, British Journal of Cancer.
[19] S. Pocock,et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.
[20] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Epidemiology.
[21] Karen A Gelmon,et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] P. Ravdin,et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] R. Blamey,et al. A prognostic index in primary breast cancer. , 1982, British Journal of Cancer.
[24] A. Jemal,et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women , 2016, CA: a cancer journal for clinicians.
[25] A. Glas,et al. Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer , 2016 .
[26] Sten Thorstenson,et al. Applying the Nottingham Prognostic Index to a Swedish breast cancer population , 2004, Breast Cancer Research and Treatment.